Recruiting NA INTERVENTIONAL 2-arm NCT05884840

New Cardiovascular Risk Screening Strategy. (HELENA)

Health Program for prEvention of cardiovascuLar disEases Based on a Risk screeNing Strategy With Ankle-brachial Index.

Sponsor: Biobizkaia Health Research Institute

Conditions Arteriosclerosis Asymptomatic Cardiovascular Prevention Peripheral Artery Disease Screening

Interventions HELENA

Updated 6 times since 2023 Last updated: Dec 22, 2023 Started: Nov 20, 2023 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Arteriosclerosis and Asymptomatic, this trial is actively recruiting participants. The trial is conducted by Biobizkaia Health Research Institute and has accumulated 6 data snapshots since 2023. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA
Sep 2024 — Feb 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2023 — Jan 2024 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jul 2023 — Sep 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biobizkaia Health Research Institute
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Hospital del Mar Research Institute (IMIM)
Institut Català de la Salut
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Data source: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain